Amneal Pharmaceuticals Files 2024 10-K

Ticker: AMRX · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1723128

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Amneal's 2024 10-K is in. Full financials and biz ops details for the year ending Dec 31, 2024.

AI Summary

Amneal Pharmaceuticals, Inc. filed its 2024 10-K report on February 28, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, previously known as Atlas Holdings, Inc., operates in the pharmaceutical preparations sector. Key financial data and business operations for the period are outlined in this comprehensive filing.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of Amneal Pharmaceuticals' financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate increased risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.

When did Amneal Pharmaceuticals, Inc. change its name from Atlas Holdings, Inc.?

The date of the name change from Atlas Holdings, Inc. to Amneal Pharmaceuticals, Inc. was November 17, 2017.

What is the filing date of this 10-K report?

This 10-K report was filed on February 28, 2025.

What is the fiscal year end for Amneal Pharmaceuticals, Inc.?

The fiscal year end for Amneal Pharmaceuticals, Inc. is December 31.

What is the SEC file number for Amneal Pharmaceuticals, Inc.?

The SEC file number for Amneal Pharmaceuticals, Inc. is 001-38485.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding Amneal Pharmaceuticals, Inc. (AMRX).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing